Showing Results for: “diabetes”

For 70 years, the American Diabetes Association (ADA) has hosted summer camps for children and teens with type 1 diabetes. In 2019 nearly 7,000 campers, their siblings, and children at-risk of type 2 diabetes, ages 4-17, will attend one of 80 camp sessions nationwide and enjoy a traditional summer camp experience in a medically-safe environment. ADA Camps create opportunities for campers to build life-long friendships, overcome feelings of isolation, and become empowered to manage their diabetes. Additionally, campers participate in physical activity and receive individualized dietary

The American Diabetes Association ® (ADA) is excited to offer Project Power for adults again this year, a no-cost lifestyle change program to empower people to reduce their risk for or manage and thrive with type 2 diabetes. Project Power is tailored for adults, ages 18+ with prediabetes, type 2 diabetes or who are at high-risk for diabetes. Participants receive a personalized program that combines health coaching, an evidence-based curriculum, and a gamified experience to help learn about disease risk reduction. “We’re on a mission to tackle the diabetes epidemic, one person and community at

Top researchers, clinicians and educators will be recognized at the 79th Scientific Sessions for outstanding leadership and work to advance diabetes research, prevention, care and treatment The American Diabetes Association (ADA) is proud to announce the recipients of the ADA’s four 2019 Professional Interest Group Awards. Individually and collectively, their exemplary leadership, mentorship and achievements have advanced the field of diabetes care and improved health outcomes for people with diabetes. “The recipients of this year’s Professional Interest Group Awards have each made significant

Improvements in Vision Impairment and Diabetes Plateaued in the Last Decade A Centers for Disease Control and Prevention (CDC) study provides new insights into vision impairment (VI) prevalence over the last 20 years. The findings demonstrate that declines in VI among adults with diabetes seen in the first decade of the 2000s may have plateaued in 2012. The findings were presented at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA) in New Orleans, LA. Diabetic retinopathy is a common and serious complication of diabetes that occurs when blood vessels in the retina are

On Nov. 28, the Centers for Medicare & Medicaid Services (CMS) released the final 2026 Home Health Rule, which makes a major change to how continuous glucose monitors (CGMs) and insulin pumps are covered for people with diabetes on Medicare. The American Diabetes Association® (ADA) is deeply concerned that this change could limit access to certain CGMs and insulin pumps and interrupt care that is currently working for patients. The ADA has spent months educating policymakers and regulators about the importance of prioritizing patient and provider choice for CGMs and insulin pumps. We continue

The American Diabetes Association ® (ADA), the leading global diabetes research, advocacy, and education organization, applauds U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME) for introducing legislation today during a joint press conference on Capitol Hill in Washington, D.C., which aims to make insulin more affordable for millions of Americans with diabetes who rely on the drug to live. The bipartisan Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act includes important reforms to reduce the price of insulin by incentivizing lower list prices and

New Studies Highlight Machine Learning as Potential Early Risk Detection Strategy Developments from two studies highlighting the potential for machine learning leveraging artificial intelligence (AI) technology to improve early-stage identification of type 1 diabetes were presented as late-breaking poster sessions at the 85 th Scientific Sessions of the American Diabetes Association ® (ADA) in Chicago. Each year, around 64,000 Americans are diagnosed with type 1 diabetes. As many as 40% are unaware they have the disease until they experience a life-threatening event that requires

Oral formulation demonstrates comparable cardiovascular benefits to injectable GLP-1s A recent study found that oral semaglutide offers meaningful cardiovascular benefits for people with type 2 diabetes, lowering risk by 14%. Results from the Semaglutide Cardiovascular Outcomes Trial (SOUL) were unveiled as a late-breaking symposia at American Diabetes Association’s® (ADA) 85th Scientific Sessions in Chicago. Adults with diabetes have 2-4 times increased cardiovascular risk compared with adults without diabetes, and the risk rises with worsening glycemic control. In fact, people living with

Senate Reconciliation Bill Would Reduce the Price of Insulin Today, Senate Democrats, including Senate Diabetes Caucus Co-Chair Sen. Jeanne Shaheen (D-NH), announced potential updates to the Inflation Reduction Act, which was released earlier this week. The Senate bill could now include a $35 monthly cap on out-of-pocket costs for insulin, and it could also allow Medicare to directly negotiate the price of insulin products with drug manufacturers. The American Diabetes Association® (ADA) has been the leading advocate for insulin copay caps across the country, resulting in the enactment of

Study of Over Three Million Patients for Risk of Type 2 Diabetes Demonstrates Potential for More Advanced Approach to Early Identification A novel electronic health record-based prediction model successfully identified patients who were at the highest risk of developing type 2 diabetes up to 10 years later. Researchers presented the findings in a general poster session and an e-Poster Theater session at the 2026 Scientific Sessions of the American Diabetes Association ® (ADA) in New Orleans. Over 60% of U.S. adults have risk factors for type 2 diabetes, far more than current diabetes